Phoenix Footwear Group, Inc. presented net income for the third quarter improving 71.3% and totaling 0.548 million USD or 0.07 US dollars per share. This compares to earnings of 0.32 million US dollars or 0.04 US dollars per share during the third quarter of fiscal 2013. Included in net income for fiscal 2013 was a nonrecurring loss from discontinued operations of 42 thousand US dollars. Excluding this loss, net income increased 51.4%.

The company's net sales from continuing operations for the third quarter reached 6.4 million US dollars (increasing 0.794 million US dollars or 14.3% from similar period in 2013), and the accumulated figures for the nine month's period increased 10.4% or 1.5 million US dollars to 16.3 million US dollars.

The increase in net sales for the quarter and first nine months of fiscal 2014 was primarily driven by sales of licensed footwear introduced during Spring 2014, together with increased sales to the company’s catalog, Internet, and national retail customers.

This resulted in net income for the first nine months of fiscal 2014 reaching 0.344 million US dollars, a 63% increase compared to similar period in 2013.

According to a statement issued by Phoenix Footwear Group, Inc.: “During the quarter, Phoenix continued its efforts to expand its distribution of key product categories resulting in accelerated growth. Notably, the company increased its presence in several national retailers including Nordstrom, Dillard’s and Uniform Advantage”.

In addition, during the quarter Phoenix Footwear Group, Inc.  also received the American Podiatric Medical Association’s (APMA) Seal of Acceptance for its Grey’s Anatomy by SoftWalk Collection. This innovative footwear for medical professionals is now sold in over 560 retail locations including many of the uniform industry’s leading retailers, such as Scrubs and Beyond, Work ‘n Gear and Uniform Advantage.